Vilon: What We Know About This Short Bioregulatory Peptide

Introduction

Vilon, also known as KE peptide (Lys-Glu), is a dipeptide with significant potential in geroprotective and immunomodulatory therapies. Research has shown that Vilon influences gene expression and protein synthesis, playing a critical role in various biological processes such as aging, inflammation, and tumor suppression. This article explores the latest scientific findings on Vilon, examining its molecular mechanisms, therapeutic potential, and dosing protocols.

Mechanisms of Action

Gene Regulation and Protein Synthesis

Vilon has been shown to regulate the expression and synthesis of key proteins involved in cell aging and rejuvenation. One significant study demonstrated that Vilon increases gene expression and SIRT1 protein synthesis in young human mesenchymal stem cells (MSCs) by 6 and 8.2 times, respectively [Khavinson et al., 2023]. SIRT1 is known for its role in promoting longevity and cellular health. Additionally, Vilon effectively reduces PARP1 and PARP2 gene expression and protein synthesis in aging MSCs, decreasing them by 2.1 to 5.3 times (PARP1) and 4.7 times (PARP2), respectively [1]. These findings suggest that Vilon modulates critical pathways involved in cellular aging, potentially extending cellular lifespan.

Anti-Inflammatory Effects

Vilon also exerts anti-inflammatory effects by influencing key proliferative and inflammatory mechanisms. In monocyte and macrophage cell lines, Vilon, alongside other peptides, decreases the production of pro-inflammatory markers like TNF and IL-6 induced by bacterial lipopolysaccharide [Avolio et al., 2022]. The peptide achieves this by enhancing TNF tolerance in monocytes, thereby attenuating inflammatory responses [2].

Mitochondrial and Ribosomal Function

Vilon has shown benefits in maintaining mitochondrial health and ribosomal protein expression during cell senescence. It increases mitochondrial staining and decreases the expression of L7A ribosomal protein in aging thymic cells, indicating a protective effect on cellular energy mechanisms and protein synthesis [Ivko et al., 2020]. These changes support the rejuvenation of cellular functions, crucial for maintaining cell vitality in older age [3].

Applications in Gerontology and Oncology

Anti-Aging and Skin Health

In gerontocosmetology, Vilon has been utilized to retard skin aging. A study reported that Vilon increases type I collagen expression by 83% in aged skin fibroblast cultures. It also enhances sirtuin-6 expression up to 2.6 times in both young and old fibroblast cultures, contributing to improved skin integrity and reduced signs of aging [Fridman et al., 2017][4].

Cancer Research

Vilon's potential extends to oncology; research on epithalon, a related peptide, shows marked inhibition of tumor growth. Although specific Phase 3 data on Vilon is limited, analogous peptides like epithalon have been shown to reduce breast adenocarcinoma size and HER-2/neu oncogene expression significantly. Such findings open intriguing possibilities for Vilon as an adjunctive therapy in cancer [Anisimov et al., 2002][6].

Phase 3 Clinical Data

Though explicit Phase 3 trials with Vilon are yet forthcoming, its analogs have shown promising results in advanced phases. For example, studies indicate successful modulation of immune responses and chromatin restructuring in elderly subjects [Khavinson et al., 2004][5].

Dosing Protocol

Vilon administration has been shown effective at low doses due to its potent activity. Standard dosing ranges around 1 microgram per kilogram of body weight administered subcutaneously for consecutive days, mimicking the successful frameworks seen with related peptides like epithalon [6]. However, individual protocols may vary based on therapeutic goals and patient response.

Key Takeaways

• Vilon is a promising bioregulatory peptide influencing gene expression and protein synthesis related to aging and inflammation.
• It offers potential therapeutic benefits in anti-aging, dermatological, and oncological fields.
• Evidence supports Vilon's role in modulating inflammatory responses and enhancing mitochondrial and ribosomal functions.
• While specific Phase 3 data for Vilon are limited, analogous peptides show compelling efficacy in similar applications.

Ask PepBot for your personalized protocol.